Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1979 4
1980 2
1982 2
1984 1
1986 1
1987 1
1993 1
1995 2
1996 2
1998 1
1999 2
2001 3
2002 1
2003 5
2004 2
2006 1
2008 1
2009 2
2010 1
2011 2
2012 2
2013 3
2014 1
2017 3
2018 3
2019 5
2020 2
2021 6
2022 2
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Results by year
Filters applied: . Clear all
Page 1
COVID-19 mRNA vaccination leading to CNS inflammation: a case series.
Khayat-Khoei M, Bhattacharyya S, Katz J, Harrison D, Tauhid S, Bruso P, Houtchens MK, Edwards KR, Bakshi R. Khayat-Khoei M, et al. Among authors: edwards kr. J Neurol. 2022 Mar;269(3):1093-1106. doi: 10.1007/s00415-021-10780-7. Epub 2021 Sep 4. J Neurol. 2022. PMID: 34480607 Free PMC article.
Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.
Levin SN, Venkatesh S, Nelson KE, Li Y, Aguerre I, Zhu W, Masown K, Rimmer KT, Diaconu CI, Onomichi KB, Leavitt VM, Levine LL, Strauss-Farber R, Vargas WS, Banwell B, Bar-Or A, Berger JR, Goodman AD, Longbrake EE, Oh J, Weinstock-Guttman B, Thakur KT, Edwards KR, Riley CS, Xia Z, De Jager PL; Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative. Levin SN, et al. Among authors: edwards kr. Ann Clin Transl Neurol. 2021 Apr;8(4):918-928. doi: 10.1002/acn3.51314. Epub 2021 Feb 22. Ann Clin Transl Neurol. 2021. PMID: 33616290 Free PMC article.
Topiramate titration and tolerability.
Biton V, Edwards KR, Montouris GD, Sackellares JC, Harden CL, Kamin M; Topiramate TPS-TR Study Group. Biton V, et al. Among authors: edwards kr. Ann Pharmacother. 2001 Feb;35(2):173-9. doi: 10.1345/aph.10093. Ann Pharmacother. 2001. PMID: 11215835 Clinical Trial.
Correlation of Regulatory T Cell Numbers with Disease Tolerance upon Virus Infection.
Graham JB, Swarts JL, Edwards KR, Voss KM, Green R, Jeng S, Miller DR, Mooney MA, McWeeney SK, Ferris MT, Pardo-Manuel de Villena F, Gale M Jr, Lund JM. Graham JB, et al. Among authors: edwards kr. Immunohorizons. 2021 Apr 23;5(4):157-169. doi: 10.4049/immunohorizons.2100009. Immunohorizons. 2021. PMID: 33893179 Free PMC article.
Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age.
Jakimovski D, Kavak KS, Vaughn CB, Goodman AD, Coyle PK, Krupp L, Gottesman M, Edwards KR, Lenihan M, Perel A, Zivadinov R, Weinstock-Guttman B; New York State Multiple Sclerosis Consortium (NYSMSC). Jakimovski D, et al. Among authors: edwards kr. Mult Scler Relat Disord. 2022 Jan;57:103406. doi: 10.1016/j.msard.2021.103406. Epub 2021 Nov 16. Mult Scler Relat Disord. 2022. PMID: 34915316
Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study.
Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Poole EM, Robinson M, Gold R. Coyle PK, et al. Among authors: edwards kr. Mult Scler Relat Disord. 2019 Jun;31:157-164. doi: 10.1016/j.msard.2019.03.022. Epub 2019 Mar 30. Mult Scler Relat Disord. 2019. PMID: 31005729 Free article. Clinical Trial.
63 results